SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
40,200
+1,400 (3.61%)
At close: May 8, 2025, 3:30 PM KST

SK bioscience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,040,7233,948,7045,528,4515,643,62717,212,500
Market Cap Growth
-28.57%-28.57%-2.04%-67.21%-
Enterprise Value
2,495,3152,813,9184,326,7794,104,200-
Last Close Price
38800.0050400.0072000.0073500.00225000.00
PE Ratio
--247.7246.0948.47
Forward PE
---24.6923.37
PS Ratio
11.3714.7614.9612.3618.53
PB Ratio
1.501.953.253.2410.75
P/TBV Ratio
1.802.343.273.2510.78
P/FCF Ratio
----34.87
P/OCF Ratio
--188.39-32.08
EV/Sales Ratio
9.3310.5211.718.99-
EV/EBITDA Ratio
--189.9628.85-
EV/EBIT Ratio
---35.68-
Debt / Equity Ratio
0.190.190.010.070.07
Debt / EBITDA Ratio
--0.900.800.22
Debt / FCF Ratio
----0.22
Asset Turnover
0.110.110.190.22-
Inventory Turnover
1.631.631.701.35-
Quick Ratio
4.344.349.564.133.68
Current Ratio
5.085.0810.204.694.00
Return on Equity (ROE)
-2.69%-2.69%1.29%7.33%-
Return on Assets (ROA)
-3.69%-3.69%-0.38%3.38%-
Return on Capital (ROIC)
-4.18%-4.18%-0.42%4.04%-
Return on Capital Employed (ROCE)
---6.50%28.70%
Earnings Yield
-1.77%-1.36%0.40%2.17%2.06%
FCF Yield
-9.62%-7.41%-0.26%-3.51%2.87%
Buyback Yield / Dilution
-0.24%-0.24%0.01%-4.32%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.